EMEA-000311-PIP06-18
Key facts
| Invented name |
Stelara
|
| Active substance |
Ustekinumab
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/0178/2019
|
| PIP number |
EMEA-000311-PIP06-18
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of Systemic Lupus Erythematosus (SLE)
|
| Route(s) of administration |
|
| Contact for public enquiries |
Janssen Cilag International NV
Tel. +3214602111 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|